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ABSTRACT  
Cancer is a heterogeneous disease characterized by uncontrolled proliferation and impaired cell cycle leading to the growth of abnormal cells 
that invade and metastasize to other parts of the body. Oxidative stress, hypoxia,  genetic mutations and lack of apoptotic function are the main 
internal causes of cancer, whereas the external causes are related to increased exposure to stress, pollution, smoking, radiation and ultraviolet 
rays. Phytochemicals derived from plants, serve as vital resources for novel drugs and are also sources for cancer therapy. The objective of this 
review is to describe the active compounds derived from the natural products/plants, along with their pharmacologic action and molecular 
targets.  
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1. INTRODUCTION 
Cancer is a serious threat and mortality of cancer are high in 
global1,2. In addition to causing serious harm to the patient's 
body, cancer also imposes a huge economic burden on 
patients, and the burden on developing countries is 
growing3. Traditionally, treatment for cancer uses the four 
methods of surgery, radiotherapy, chemotherapy, and 
immunotherapy alone or in combination4. Accompanied by 
the use of chemotherapy drugs, drug resistance caused by 
cancer cells adapting to chemotherapeutic agents is the main 
reason for obstructing the efficacy of chemotherapy drugs5. 
Therefore, the development of adjuvant or alternative drugs 
is necessary. Biologically active phytochemicals present in 
plants and natural products, improve treatment efficiency in 
cancer patients and decrease adverse reactions. These 
phytochemicals having significant antitumor potential6 .In 
the present review, an attempt has been made to collect 
information about the anti-cancer phytochemicals that are 
evaluated at preclinical and clinical levels. 
2. PHYTOCHEMICALS USED IN CURRENT CANCER 
TREATMENT 
Scientific evidences indicate that phytochemicals have 
significant antitumor potential. Approximately, 50% of 
approved anticancer drugs originate from natural 
products7,6. These phytochemicals have been tested for anti-
cancer efficacy at both in vitro and in vivo levels. They 
possess complementary and overlapping mechanisms to 
slow down the carcinogenic process by scavenging free 
radicals8, suppressing survival and proliferation of 
malignant cells9, as well as diminishing invasiveness and 
angiogenesis of tumors10. They exert wide and complex 
range of actions on different molecular targets and signal 
transduction pathways including membrane receptors11, 
kinases12, downstream tumor-activator or -suppressor 
proteins13, transcriptional factors14, microRNAs (miRNAs)15, 
cyclins, and caspases9. 
The four major classes of clinically used plant-derived 
anticancer compounds include vinca alkaloids, taxane 
diterpenoids, camptothecin derivatives, and 
epipodophyllotoxin (Table 1). Apart from these 
phytochemical classes, other plant-derived anticancer 
agents from different classes such as combretastatins, 
homoharringtonine (omacetaxine mepesuccinate, 
cephalotaxine alkaloid), and ingenol mebutate are also used 
(Table 1). 
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Table 1: Phytochemicals used in current cancer treatment 
Phytochemicals Pharmacological action Type of cancer Ref 
Vinca alkaloids 
Vinblastine, Vincristine, 
Vindesine , Vinflunine, 
Vinorelbine 
Inhibit microtubule polymerization 
and assembly, leading to metaphase 
arrest and cell death. 
Non-small-cell lung carcinoma 
(NSCLC), breast, lung, leukemia, 
Hodgkin and non-Hodgkin 
lymphomas, testicular carcinoma, 
Kaposi’s sarcoma, and second-line 
transitional cell carcinoma of the 
urothelium (TCCU) 
16 
Taxanes  
Cabazitaxel, Docetaxel, 
Paclitaxel 
Inhibit microtubule function resulting 
in cell cycle arrest and aberrant 
mitosis. 
NSCLC, head and neck, breast, 
prostate, gastric adenocarcinoma 
17,18 
Podophyllotoxin 
Etoposide, Teniposide 
Inhibits DNA synthesis by forming a 
complex with topoisomerase II and 
DNA. 
Osteosarcoma, NSCLC cervical, 
nasopharyngeal, colon, breast, 
prostate, and testicular cancer 
19 
 
Camptothecin  
 Irinotecan , Topotecan 
Stabilizes topoisomerase I-DNA 
complex thereby preventing religation 
of single strand breaks resulting in 
lethal double-stranded breaks in DNA. 
Ovarian, cervical, colorectal, and 
small cell lung cancer (SCLC) 
20 
Combretastatin A4 Inhibits polymerization of tubulin 
causing disruption of the tumor 
endothelial cells lining the tumor 
vasculature 
Polypoidal choroidal vasculopathy, 
anaplastic thyroid cancers 
21 
Homoharringtonine Binds to large ribosomal subunit, 
which affects chain elongation and 
prevents protein synthesis 
Chronic myeloid leukemia 22 
Ingenol mebutat It induces rapid induction of cell death 
in the treated area and it activates 
inflammatory response, capable of 
eliminating the residual cells 
Actinic keratosis 
 
23 
Homoharringtonine (HHT) HHT binds to the A-site cleft in the 
large ribosomal subunit, which affects 
chain elongation and prevents protein 
synthesis. 
Chronic myeloid leukemia 24 
Combretastatins 
compounds 
Combretastatin A1 , 
Combretastatin A4 , 
Combretastatin A4 
phosphate (CA4P) 
These compounds indirectly act on 
cancer cells by inhibiting tubulin 
polymerization causing disruption of 
the tumor endothelial cells lining the 
tumor vasculature, inducing rapid 
vascular collapse in solid tumors 
Thyroid and ovarian cancer. 21 
Resveratrol (stilbenoid) Delayed the development of 
recurrence by lengthening the prostate 
specific antigen doubling time 
(PSADT) 
Low-grade GI neuroendocrine 
tumors 
25 
Paclitaxel (tricyclic 
diterpenoid) 
Effectiveness on both solid and 
disseminated tumors and a broad 
spectrum of antitumor activity 
predicted by its unique  mechanism of 
action, which targets the very basic 
elements of the cancer phenotype like 
cell proliferation 
breast, ovarian  
and lung cancers 
26  
 
3. PHYTOCHEMICALS USED AS CANCER 
CHEMOPREVENTIVE AND TREATMENT AGENTS 
Various review articles summarized natural phytochemicals 
and their anti-cancer effects, such as Vitamin E from plant 
oil27 boron-rich natural compound28 , hydroxytyrosol from 
virgin olive oil29 , resveratrol from grapes30, phytoestrogens 
most notably from soybean31, or EGCG from green tea 
polyphenols32. Abundant evidence has been collected on 
preclinical efficacy of number of phytochemicals in various 
animal models which is summarized in Table 2 and Fig.1.
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Table 2: Phytochemicals used in cancer therapy 
Phytochemicals  Source Pharmacological action Types of Cancer Ref 
Allicin (organosulfurs) Garlic (Allium sativum) STAT3 signaling pathway Lung adenocarcinoma A549 and 
H1299 cells  
33,34 
Andrographolide 
(diterpenoid) 
Green chireta 
(Andrographis 
paniculata) 
HIF-1a, VEGF, and PI3K 
pathway 
HT-29 cells 35 
Apigenin (flavonoid) Parsley (Petroselinum 
crispum) 
Intrinsic apoptosis 
pathway 
Human chondrosarcoma Sw1353 
cells 
36,9 
Baicalein (flavonoid)  Baikal skullcap  
(Scutellaria 
baicalensis) 
MAPK, ERK, and p38 
signaling pathways 
Human colon cancer HCT116 cells 12,37 
Curcumin 
(phytopolyphenol) 
Turmeric (Curcuma 
longa) 
Modulates cell signaling 
and gene expression 
regulatory pathways 
 Human A375 melanoma cells 38 
Dicumarol Yellow sweet clover 
(Melilotus officinalis) 
Intrinsic apoptosis 
pathway 
DIC as a potential anticancer agent 
when female fertility preservation 
is a concern  
14,39 
Epigallocatechin 
(flavonoids) 
Green tea (Camellia 
sinensis) 
Inhibit cell proliferation 
and apoptosis 
Human breast cancer MDA-MB-231 
cells 
40 
Emodin - 
Resin(anthraquinone 
derivative) 
Root and rhizome 
of Rheum palmatum L. 
PI3K/AKT and MAPK 
signaling pathways 
Human hepatocellular cancer 
SMMC-7721 cells 
41,42 
Genistein 
(isoflavonoid) 
Soya beans (Glycine 
max (legumes) 
WNT/b-catenin and Akt 
signaling pathway 
Human leukemia cell line HL‐60 43 
Gingerol (polyphenol) Rhizomes of 
ginger (Zingiber 
officinale) 
Intrinsic apoptosis 
pathway 
 Inhibition of lung-metastatic, MDA-
MB-231 human breast cancer cell 
proliferation 
44,45 
Glycyrrhizin 
(triterpenes) 
Roots of licorice  
(Glycyrrhiza glabra) 
TxA2 and JAK/STAT 
signaling pathway 
Human lung adenocarcinoma A549 
cells  
46 
Hispidulin (flavone) Roseleaf sage (Salvia 
involucrate) 
Intrinsic apoptosis 
pathway 
Inhibited the Caki-2 (human clear 
cell renal cell carcinoma) tumor 
growth,  Human hepatocellular 
carcinoma Bel7402 cell 
47,48 
Licochalcone A 
(chalcone) 
Roots of Liquorice 
(Glycyrrhiza glabra) 
Cyclins and CDKs Human cervical cancer cell SiHa 10 
Nimbolide (triterpene) Neem (Azadirachta 
indica) 
PI3K/AKT/mTOR and ERK 
signaling 
Pancreatic cancer HPAC cell 49 
Pterostilbene 
(polyphenol) 
Grapes (Vitis vinifera, 
Vitaceae) 
Mitochondrial mediated 
apoptosis; ERK and STAT3 
signaling 
Inhibited EC109 tumor growth 50 
Sulforaphane 
(organosulfur) 
Cabbage (Brassica 
oleracea) 
Cell cycle arrest and 
apoptosis. Targets: caspase 
8, p21, hsp90 
Barrett esophageal 
adenocarcinoma (BEAC) cells 
51 
Thymol 
(monoterpenoids) 
Thyme (Thymus 
vulgaris) and Oregano 
(Origanum vulgare) 
Mitochondrial mediated 
apoptosis 
Oral squamous cell carcinoma 
Cal27‐ and HeLa‐ 
52 
Thymoquinone 
(quinone) 
Black cumin seed oil 
(Nigella sativa) 
STAT3 and associated 
protein 
Human gastric cancer cells, breast 
cancer EMT6/P cell line 
53 
Ursolic acid 
(triterpenoids) 
Snake-needle grass 
(Oldenlandia diffusa) 
Ki-67, CD31, and miR-29a Cervical cancer cell 54 
Withaferin-A 
(phytosterols) 
Ashwagandha 
(Withania somnifera) 
AKT signaling FOX03a-Par-
4 cell death pathway, ERK, 
and p38 pathway 
Human colorectal carcinoma (HCT-
116) cells 
55 
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Fig.1: Chemical structures of some anticancer phytochemicals 
 
4. FLAVONOIDS AS ANTICANCER AGENTS 
Flavonoids are polyphenolic compounds subdivided into 6 
groups: isoflavonoids, flavanones, flavanols, flavonols, 
flavones and anthocyanidins found in a variety of plants. 
Fruits, vegetables, plant-derived beverages such as green 
tea, wine and cocoa-based products are the main dietary 
sources of flavonoids. Flavonoids have been shown to 
possess a wide variety of anticancer effects: they modulate 
reactive oxygen species (ROS)-scavenging enzyme activities, 
participate in arresting the cell cycle, induce apoptosis, 
autophagy, and suppress cancer cell proliferation and 
invasiveness. Flavonoids have dual action regarding ROS 
homeostasis—they act as antioxidants under normal 
conditions and are potent pro-oxidants in cancer cells 
triggering the apoptotic pathways and down regulating pro-
inflammatory signaling pathways56. Flavonoids exert a wide 
variety of anticancer effects: they modulate ROS-scavenging 
enzyme activities, participate in arresting the cell cycle, 
induce apoptosis, autophagy, and suppress cancer cell 
proliferation and invasiveness57, 58. Isoflavone genistein 
promoted breast cancer cell arrest at G2/M phase and 
subsequent ROS dependent apoptosis59. Daidzein promoted 
apoptosis in breast cancer MCF-7 cells due to the ROS 
generation60. Flavanone hesperetin induced apoptosis of gall 
bladder carcinoma61, esophageal cancer5, hepatocellular 
carcinoma and human breast carcinoma MCF-7 cells62 via 
activating the mitochondrial apoptotic pathway by 
increasing the ROS production. Flavanone naringenin 
exerted anti-cancer effects on choriocarcinoma JAR and JEG 
3 cell lines by inducing the generation of ROS and activation 
of signaling pathways63. Cocoa catechins and procyanidins 
have been shown to induce apoptotic morphological 
changes, DNA damage and apoptosis in epithelial ovarian 
cancer cells due to their prooxidant properties64. Cocoa 
polyphenolic extract activated the ERK1/2 pathway, thus 
increasing the activities of glutathione peroxidase and 
reductase in HepG2 cells. Flavonol quercetin exerted potent 
cancer chemopreventive properties. Recent studies showed 
that quercetin reduced the proliferation of hepatocellular 
carcinoma HepG2 cells decreasing the intracellular ROS 
level65. Flavonol kaempferol exerted cytotoxic effects on rat 
hepatocellular carcinoma cells via ROS-mediated 
mitochondrial targeting66. The anticancer activities of 
flavones apigenin and luteolin in ovarian cancer cell lines 
(A2780, OVCAR-3 and SKOV-3) were also related to the 
changes in ROS signaling, as well as to the promotion of 
apoptosis67. Flavone chrysin was reported to augment ROS 
and lipid peroxidation levels, leading to the death of 
choriocarcinoma (JAR and JEG3), bladder cancer and ovarian 
cancer (ES2 and OV90) cells68. Thus, numerous studies show 
beneficial effects of flavonoids as potent antioxidants under 
normal and pro-oxidants under pathological conditions, 
capable of activating apoptosis and suppressing 
proliferation and inflammation. 
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5. CONCLUSION 
Cancer is a highly malignant disease. Based on its current 
status, it is urgent to explore a kind of drug with lower 
toxicity, lower side effects and effective drug for cancer 
treatment or adjuvant therapy. The tumor occurrence and 
development involve multiple links, multiple pathways, and 
multiple targets. The complexity of the interaction between 
the various links may lead to clinical reactions such as 
limited therapeutic effect and large side effects. In this 
review, an attempt has been made to provide information of 
phytochemicals that are used in cancer treatment. This 
information will be extremely useful to identify a series of 
additional plant-derived drugs to treat cancer with 
minimum side effects. 
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